Cantillon Capital Management LLC grew its holdings in shares of CME Group Inc (NASDAQ:CME) by 0.7% during the fourth quarter, HoldingsChannel reports. The firm owned 1,936,162 shares of the financial services provider’s stock after purchasing an additional 13,400 shares during the period. CME Group accounts for about 4.4% of Cantillon Capital Management LLC’s portfolio, making the stock its 6th largest position. Cantillon Capital Management LLC’s holdings in CME Group were worth $364,231,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in CME. Ruggie Capital Group bought a new position in CME Group in the 4th quarter worth $28,000. Nelson Roberts Investment Advisors LLC bought a new position in CME Group in the 4th quarter worth $33,000. Ipswich Investment Management Co. Inc. bought a new position in CME Group in the 4th quarter worth $47,000. Contravisory Investment Management Inc. raised its holdings in CME Group by 197.6% in the 4th quarter. Contravisory Investment Management Inc. now owns 253 shares of the financial services provider’s stock worth $48,000 after acquiring an additional 168 shares during the period. Finally, Alpha Windward LLC raised its holdings in CME Group by 820.0% in the 4th quarter. Alpha Windward LLC now owns 322 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 287 shares during the period. Institutional investors and hedge funds own 85.80% of the company’s stock.
NASDAQ:CME opened at $178.20 on Friday. CME Group Inc has a 52-week low of $152.50 and a 52-week high of $197.08. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15. The stock has a market cap of $60.56 billion, a PE ratio of 37.36, a P/E/G ratio of 2.18 and a beta of 0.30.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be issued a dividend of $0.75 per share. This is an increase from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date is Thursday, March 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.68%. CME Group’s payout ratio is presently 58.70%.
In other news, Director Charles P. Carey sold 5,000 shares of CME Group stock in a transaction dated Wednesday, November 21st. The shares were sold at an average price of $191.84, for a total transaction of $959,200.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Julie Winkler sold 5,847 shares of CME Group stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the sale, the insider now owns 24,255 shares in the company, valued at $4,729,967.55. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,494 shares of company stock worth $9,967,852. Insiders own 0.43% of the company’s stock.
Several brokerages recently commented on CME. Citigroup began coverage on shares of CME Group in a report on Tuesday, November 20th. They issued a “buy” rating and a $220.00 target price on the stock. Berenberg Bank upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 target price on the stock in a report on Tuesday, November 20th. Atlantic Securities initiated coverage on shares of CME Group in a report on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price objective on the stock. UBS Group downgraded shares of CME Group from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $185.00 to $204.00 in a report on Wednesday, November 28th. Finally, Deutsche Bank boosted their price objective on shares of CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a report on Friday, November 16th. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $195.21.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Story: Cost of Goods Sold (COGS)
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.